28 October 2019
AIM: CER
Cerillion plc
("Cerillion" or "the Company")
Trading Update
Cerillion, the billing, charging and customer relationship management ("CRM") software solutions provider, is pleased to provide a trading update for its financial year ended 30 September 2019.
Results for the year are expected to be in line with market expectations, with revenues rising by 8% to c. £18.7m (2018: £17.4m) and adjusted EBITDA up by 14% to c. £4.5m (2018: £3.9). The Company's net cash position has grown strongly year-on-year and is expected to stand at c. £5.0m (2018: £2.5m), which is ahead of market forecasts.
As anticipated in the Company's Interim Results in May, trading has been significantly second half weighted this year due to the timing of contract closures. The second half of the year saw Cerillion sign three major contracts, with these new wins continuing the trend towards larger deal sizes. Over the year, major new contracts were secured from all the Company's key international geographies, Europe, the Americas and Asia-Pacific.
This good progress, together with an encouraging pipeline of further business opportunities, has set a strong foundation for continuing progress in the new financial year.
The Company intends to announce full year results on 25 November 2019.
Cerillion plc |
c/o KTZ Communications |
Louis Hall, CEO |
T: 020 3178 6378 |
Oliver Gilchrist, CFO |
|
|
|
Shore Capital (Nomad and broker) |
T: 020 7408 4090 |
Toby Gibbs, Mark Percy |
|
|
|
KTZ Communications |
T: 020 3178 6378 |
Katie Tzouliadis, Dan Mahoney |
|
About Cerillion
www.cerillion.com
Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 90 customer installations across over 40 countries.
Headquartered in London, Cerillion also has operations in Pune, India, where its Global Solutions Centre is located, Miami and Sydney.